ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

New PatentVest Pulse Report Reveals Transformative Trends in Portable ECG Monitoring

  • 56% increase in global patent publications over the last five years signals growing interest in the cardiac monitoring market which is expected to grow to $3 billion per year by 2029 according to Statista.
  • PatentVest’s report provides groundbreaking insights into the evolving landscape of cardiac care, highlighting key players, technological advancements and the race for innovation.

Dallas, TX, May 22, 2024 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announces the release of its latest report, "Pulse of Innovation: Shaping the Future of Cardiac Health Through Technology." This comprehensive study offers a deep dive into the rapidly evolving world of portable ECG monitoring, uncovering transformative trends in IP filings that forecast the future of the cardiac care industry.

The report highlights the seismic shift underway in cardiac monitoring, driven by the convergence of wearable devices, artificial intelligence, and cloud connectivity. Key findings include:

  • Technological Advancements: Portable ECG monitors capable of detecting arrhythmias and myocardial infarction, AI algorithms for predictive cardiac risk analysis, and seamless integration with smartphones and telehealth platforms.
  • Competitive Landscape: Insights into industry giants like Philips, Huawei, and Asahi Kasei, as well as ambitious startups such as HeartBeam, Vivalink, Vektor Medical, and Biointellisense, all vying for dominance in the market.
  • Intellectual Property Trends: Patent filing trends show a 56% increase in global patent publications over the last five years, indicating a strong increase in interest and innovation in the space.

"Our report uncovers the cutting-edge technologies and competitive dynamics shaping the future of cardiac health," said Chris Marlett, CEO at PatentVest. "As the industry continues to evolve, understanding these trends is essential for companies looking to stay ahead of the curve and drive innovation in cardiac care."

The "PatentVest Pulse" report is now available for download on the PatentVest website PatentVest Pulse. For more information or inquiries, please contact info@patentvest.com.

The insights and analysis presented in this report, were derived from IP Research work performed for HeartBeam, an active client of our firm. Our affiliated company, MDB Capital, has performed services for and owns an equity interest in HeartBeam.

About PatentVest
PatentVest, a division of MDB Capital Holdings (Nasdaq: MDBH), is the first integrated IP intelligence, strategy, and law firm to enable visionary companies to develop into technology leaders. By combining our proprietary database with a time proven IP diligence process and expert analysis, we deliver actionable insights on the IP landscape to help our clients make informed decisions and stay ahead of the curve. The trends and competitive insights in this report are powered by PatentVest's proprietary IP intelligence platform. Our reports keep a pulse on the key players, technologies, and opportunities shaping deep technology markets.


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  248.40
+0.00 (0.00%)
AAPL  269.43
+0.00 (0.00%)
AMD  243.98
+0.00 (0.00%)
BAC  53.42
+0.00 (0.00%)
GOOG  290.59
+0.00 (0.00%)
META  631.76
+0.00 (0.00%)
MSFT  506.00
+0.00 (0.00%)
NVDA  199.05
+0.00 (0.00%)
ORCL  240.83
+0.00 (0.00%)
TSLA  445.23
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.